Payment overview · 2025
General Payments
$290.63
12 reported records · 6 companies
Healthcare provider profile · identity verified
Ilya Rachman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · RESEDA, CA · NPI 1255463204
Verified facts
What the public records show
CMS Open Payments records show Ilya Rachman, M.D. received $290.63 in general payments during 2025 across 12 reported records.
Novartis Pharmaceuticals Corporation accounted for 27.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Entresto, Linzess, Trelegy Ellipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 233 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 393 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 116 claims for Synthroid by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Prolia by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 258 claims for Trelegy Ellipta by this doctor in 2024.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 415 claims for Entresto by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $79.36 | 27.3% | 3 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $70.54 | 24.3% | 3 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $60.02 | 20.6% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $46.55 | 16.0% | 2 | 2025 |
| SCPHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $20.66 | 7.1% | 1 | 2025 |
| Kowa Pharmaceuticals America, Inc. | Unresolved — no canonical attribution shown | $13.50 | 4.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $290.63 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $79.36 | 3 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $60.02 | 2 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $47.06 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $27.09 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $27.09 | 1 | 2025 |
Source payment records
|
|||||
| ENTRESTO Normalized: entresto |
Drug | Novartis Pharmaceuticals Corporation | $24.64 | 1 | 2025 |
Source payment records
|
|||||
| CREON Normalized: creon |
Drug | ABBVIE INC. | $23.48 | 1 | 2025 |
Source payment records
|
|||||
| FUROSCIX Normalized: furoscix |
Drug | SCPHARMACEUTICALS INC. | $20.66 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $19.46 | 1 | 2025 |
Source payment records
|
|||||
| ZORYVE Normalized: zoryve |
Drug | Kowa Pharmaceuticals America, Inc. | $13.50 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 233 | exact normalized | Medicare Part D |
| ENTRESTO entresto |
2025 | Entresto | 2024 | 415 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 393 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 258 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
233 | 40 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
393 | 49 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
116 | 13 |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
30 | 21 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
258 | 32 |
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
415 | 53 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1840 | 214 |
| Diclofenac Sodium | Diclofenac Sodium | 1266 | 138 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1227 | 160 |
| Azelastine Hcl | Azelastine Hcl | 1202 | 158 |
| Spironolactone | Spironolactone | 1126 | 124 |
| Gabapentin | Gabapentin | 1116 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 887 | 108 |
| Losartan Potassium | Losartan Potassium | 836 | 105 |
| Tamsulosin Hcl | Tamsulosin Hcl | 818 | 98 |
| Clopidogrel | Clopidogrel Bisulfate | 816 | 89 |
| Lidocaine | Lidocaine | 755 | 91 |
| Metformin Hcl | Metformin Hcl | 734 | 107 |
| Amlodipine Besylate | Amlodipine Besylate | 719 | 89 |
| Dexlansoprazole Dr | Dexlansoprazole | 678 | 75 |
| Allopurinol | Allopurinol | 674 | 81 |
| Omeprazole | Omeprazole | 666 | 87 |
| Ozempic | Semaglutide | 645 | 88 |
| Famotidine | Famotidine | 643 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 609 | 72 |
| Trazodone Hcl | Trazodone Hcl | 604 | 77 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 594 | 71 |
| Icosapent Ethyl | Icosapent Ethyl | 564 | 63 |
| Carvedilol | Carvedilol | 551 | 65 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 541 | 66 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 537 | 64 |
| Metformin Er Gastric | Metformin Hcl | 535 | 53 |
| Celecoxib | Celecoxib | 514 | 61 |
| Furosemide | Furosemide | 486 | 63 |
| Hydrochlorothiazide | Hydrochlorothiazide | 464 | 50 |
| Nebivolol Hcl | Nebivolol Hcl | 432 | 45 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 432 | 47 |
| Fluticasone Propionate | Fluticasone Propionate | 416 | 57 |
| Entresto | Sacubitril/Valsartan | 415 | 53 |
| Mounjaro | Tirzepatide | 396 | 59 |
| Linzess | Linaclotide | 393 | 49 |
| Eliquis | Apixaban | 382 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 374 | 55 |
| Ezetimibe | Ezetimibe | 370 | 36 |
| Jardiance | Empagliflozin | 361 | 37 |
| Clonidine Hcl | Clonidine Hcl | 351 | 40 |
| Dicyclomine Hcl | Dicyclomine Hcl | 346 | 46 |
| Sertraline Hcl | Sertraline Hcl | 345 | 42 |
| Metformin Hcl Er | Metformin Hcl | 326 | 48 |
| Mirtazapine | Mirtazapine | 301 | 31 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 258 | 32 |
| Finasteride | Finasteride | 250 | 37 |
| Montelukast Sodium | Montelukast Sodium | 245 | 24 |
| Topiramate | Topiramate | 245 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 235 | 30 |
| Creon | Lipase/Protease/Amylase | 233 | 40 |
| Dapagliflozin | Dapagliflozin Propanediol | 230 | 27 |
| Memantine Hcl Er | Memantine Hcl | 226 | 20 |
| Ibuprofen | Ibuprofen | 218 | 36 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 216 | 30 |
| Donepezil Hcl | Donepezil Hcl | 213 | 26 |
| Potassium Chloride | Potassium Chloride | 212 | 25 |
| Colchicine | Colchicine | 209 | 29 |
| Febuxostat | Febuxostat | 207 | 21 |
| Tavaborole | Tavaborole | 203 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 194 | 26 |
| Vascepa | Icosapent Ethyl | 192 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 184 | 29 |
| Meclizine Hcl | Meclizine Hcl | 183 | 21 |
| Diclofenac Epolamine | Diclofenac Epolamine | 182 | 21 |
| Trulicity | Dulaglutide | 176 | 24 |
| Eplerenone | Eplerenone | 175 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 172 | 25 |
| Repatha Sureclick | Evolocumab | 167 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 165 | 16 |
| Mometasone Furoate | Mometasone Furoate | 165 | 19 |
| Baclofen | Baclofen | 159 | 21 |
| Simvastatin | Simvastatin | 159 | 27 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 156 | 14 |
| Diflorasone Diacetate | Diflorasone Diacetate | 154 | 16 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 153 | 18 |
| Alendronate Sodium | Alendronate Sodium | 152 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 152 | 26 |
| Pitavastatin Calcium | Pitavastatin Calcium | 149 | 19 |
| Bupropion Xl | Bupropion Hcl | 145 | 14 |
| Atenolol | Atenolol | 141 | 24 |
| Valsartan | Valsartan | 140 | 14 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 138 | 16 |
| Xarelto | Rivaroxaban | 137 | 16 |
| Farxiga | Dapagliflozin Propanediol | 136 | 24 |
| Meloxicam | Meloxicam, Submicronized | 136 | 14 |
| Solifenacin Succinate | Solifenacin Succinate | 135 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 135 | 16 |
| Primidone | Primidone | 134 | 15 |
| Clotrimazole | Clotrimazole | 133 | 13 |
| Memantine Hcl | Memantine Hcl | 132 | 20 |
| Dutasteride | Dutasteride | 130 | 14 |
| Nitroglycerin | Nitroglycerin | 130 | 22 |
| Meloxicam | Meloxicam | 129 | 17 |
| Telmisartan | Telmisartan | 128 | 19 |
| Myrbetriq | Mirabegron | 117 | 22 |
| Synthroid | Levothyroxine Sodium | 116 | 13 |
| Hydrocortisone Butyrate | Hydrocortisone Butyrate | 115 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 115 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 113 | 11 |
| Benazepril Hcl | Benazepril Hcl | 111 | 18 |
| Clobetasol Propionate | Clobetasol Propionate | 110 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 108 | 14 |
| Econazole Nitrate | Econazole Nitrate | 107 | 11 |
| Inpefa | Sotagliflozin | 106 | 14 |
| Lubiprostone | Lubiprostone | 106 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 106 | 17 |
| Lisinopril | Lisinopril | 105 | 19 |
| Sumatriptan Succinate | Sumatriptan Succinate | 105 | 15 |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 102 | 12 |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 100 | 12 |
| Dexilant | Dexlansoprazole | 99 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 99 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 94 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 94 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 94 | 29 |
| Aripiprazole | Aripiprazole | 91 | suppressed |
| Hydrocortisone | Hydrocortisone | 90 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 89 | suppressed |
| Procto-Med Hc | Hydrocortisone | 89 | suppressed |
| Nifedipine Er | Nifedipine | 87 | 12 |
| Acyclovir | Acyclovir | 83 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 83 | 11 |
| Januvia | Sitagliptin Phosphate | 81 | 15 |
| Sildenafil Citrate | Sildenafil Citrate | 77 | suppressed |
| Lactulose | Lactulose | 76 | suppressed |
| Sumatriptan Succ-Naproxen Sod | Sumatriptan Succ/Naproxen Sod | 76 | suppressed |
| Mirabegron Er | Mirabegron | 75 | 13 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 73 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 72 | suppressed |
| Ranolazine Er | Ranolazine | 70 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 68 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 67 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 65 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 64 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 64 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 62 | suppressed |
| Glimepiride | Glimepiride | 61 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 60 | suppressed |
| Ramelteon | Ramelteon | 60 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 59 | suppressed |
| Fenofibrate | Fenofibrate | 58 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 58 | suppressed |
| Tadalafil | Tadalafil | 57 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 55 | 20 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 55 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 54 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 54 | suppressed |
| Mupirocin | Mupirocin Calcium | 54 | suppressed |
| Risperidone | Risperidone | 53 | suppressed |
| Calcitriol | Calcitriol | 52 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 52 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 52 | suppressed |
| Silodosin | Silodosin | 51 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 51 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 50 | 11 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 50 | 11 |
| Livalo | Pitavastatin Calcium | 50 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 11 |
| Imipramine Hcl | Imipramine Hcl | 49 | suppressed |
| Mupirocin | Mupirocin | 47 | suppressed |
| Norgesic Forte | Orphenadrine/Aspirin/Caffeine | 47 | suppressed |
| Roflumilast | Roflumilast | 47 | suppressed |
| Dulera | Mometasone/Formoterol | 45 | suppressed |
| Lansoprazole | Lansoprazole | 45 | suppressed |
| Nystatin | Nystatin | 45 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 45 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 43 | suppressed |
| Ketoconazole | Ketoconazole | 43 | suppressed |
| Praluent Pen | Alirocumab | 43 | suppressed |
| Trulance | Plecanatide | 43 | suppressed |
| Chlorzoxazone | Chlorzoxazone | 42 | suppressed |
| Estradiol | Estradiol | 42 | 11 |
| Fluocinonide | Fluocinonide | 41 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 41 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 40 | suppressed |
| Ondansetron Odt | Ondansetron | 40 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 40 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 39 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 39 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 39 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 39 | suppressed |
| Ursodiol | Ursodiol | 39 | suppressed |
| Cyclobenzaprine Hcl Er | Cyclobenzaprine Hcl | 38 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 38 | suppressed |
| Zileuton Er | Zileuton | 38 | suppressed |
| Cilostazol | Cilostazol | 37 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 37 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 37 | suppressed |
| Tradjenta | Linagliptin | 37 | suppressed |
| Digoxin | Digoxin | 36 | suppressed |
| Dihydroergotamine Mesylate | Dihydroergotamine Mesylate | 35 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 35 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 34 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 34 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 33 | suppressed |
| Pregabalin | Pregabalin | 33 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 32 | 13 |
| Nitroglycerin Patch | Nitroglycerin | 32 | suppressed |
| Rivastigmine | Rivastigmine | 32 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 25 |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 30 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 30 | suppressed |
| Prolia | Denosumab | 30 | 21 |
| Alprazolam | Alprazolam | 29 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Cyclosporine | Cyclosporine | 28 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 28 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 28 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 26 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Benicar | Olmesartan Medoxomil | 25 | suppressed |
| Rybelsus | Semaglutide | 25 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Olopatadine Hcl | Olopatadine Hcl | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Nexium | Esomeprazole Magnesium | 22 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 22 | suppressed |
| Latanoprost | Latanoprost | 21 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Loperamide | Loperamide Hcl | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Epinephrine | Epinephrine | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Testosterone | Testosterone | 19 | suppressed |
| Calcipotriene | Calcipotriene | 18 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 18 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Prednisone | Prednisone | 18 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 17 | suppressed |
| Topiramate Er | Topiramate | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 17 | suppressed |
| Voquezna | Vonoprazan Fumarate | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 16 | suppressed |
| Risperidone Odt | Risperidone | 16 | suppressed |
| Serostim | Somatropin | 16 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Amitiza | Lubiprostone | 15 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Crestor | Rosuvastatin Calcium | 15 | suppressed |
| Edarbi | Azilsartan Medoxomil | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 15 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Efavirenz-Emtric-Tenofov Disop | Efavirenz/Emtricit/Tenofovr Df | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Nitro-Bid | Nitroglycerin | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Ethacrynic Acid | Ethacrynic Acid | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Oxiconazole Nitrate | Oxiconazole Nitrate | 13 | suppressed |
| Ritonavir | Ritonavir | 13 | suppressed |
| Singulair | Montelukast Sodium | 13 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 13 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 12 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 12 | suppressed |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Flector | Diclofenac Epolamine | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Misoprostol | Misoprostol | 12 | suppressed |
| Plavix | Clopidogrel Bisulfate | 12 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 12 | suppressed |
| Sulindac | Sulindac | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Darunavir | Darunavir | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Kerendia | Finerenone | 11 | suppressed |
| Proctozone-Hc | Hydrocortisone | 11 | suppressed |
| Repatha Pushtronex | Evolocumab | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Toviaz | Fesoterodine Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $290.63 · 12 records | Novartis Pharmaceuticals Corporation | CREON, ENTRESTO, EVENITY, FUROSCIX, LEQVIO, LINZESS, OTEZLA, REPATHA, TRELEGY ELLIPTA, ZORYVE | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error